Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Journey Medical Corp (DERM)
Market is closed
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.04 | 10,000 | Director | 144,245 | 2024-03-25 | Filing | |
| $3.48 | 10,000 | Officer, Director | 2,163,430 | 2024-03-22 | Filing | |
| $3.47 | 30,000 | Director | 134,717 | 2024-03-22 | Filing | |
| $3.40 | 20,000 | Director | 134,245 | 2024-03-22 | Filing | |
| $2.98 | 33,000 | Director | 104,717 | 2023-10-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.01 | 49,271 | Officer, Director | 2,003,147 | 2025-03-11 | Filing | |
| $5.01 | 14,905 | Officer, Director | 2,052,418 | 2025-03-07 | Filing | |
| $5.04 | 25,551 | Officer, Director | 2,067,323 | 2025-03-06 | Filing | |
| $5.13 | 18,147 | Officer, Director | 2,092,874 | 2025-03-05 | Filing | |
| $5.04 | 28,901 | Officer, Director | 2,111,021 | 2025-03-04 | Filing |
News See All
10 Cheap Hot Stocks to Buy Right Now
Periods of high market volatility can make cheap stocks attractive because sharp price swings may undervalue fundamentally strong growth companies in the short run.
Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (DERM): A Bull Case Theory
We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM.
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the same can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good day, and welcome to Journey Medical's Second Quarter 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to Journey Medical’s Third Quarter 2023 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q2 2023 Earnings Call Transcript
Operator: Ladies and Gentleman, thank you for standing by. Good afternoon and welcome to Journey Medical Second Quarter 2023 Financial Results and Corporate Update conference call.
Journey Medical Corporation (NASDAQ:DERM) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical's First Quarter 2023 Financial Results and Corporate Update Conference Call.
Billionaire Hedge Funds
